What is fluoroquinolone resistance?
fluoroquinolone resistance is a term used by reference to the fact that certain types of bacteria no longer respond to the treatment of fluoroquinolones, class of antibiotic drugs that include ciprofloxacin. In some areas, there could be a high percentage of individuals in whom fluoroquinolone drugs are not effective against infectious diseases such as E. coli or salmonel. Some public health officials urged medical professions to be careful when prescribing certain drug combinations, due to concerns about the potential development of tuberculosis that demonstrates fluoroquinolone resistance. Drugs known as fluoroquinolones are among the most commonly used antibiotics, both in human and veterinary medicine. Some sources indicate extensive veterinary use of these drugs in European countries. Fluoroquinolone drugs, such as ciprofloxacin, are considered particularly effective for the treatment of certain types of tuberculosis in humans.
A rise in fluoroqodolnost against uinolone around the world is said to beattributed to inappropriate prescription of this type of drug for less serious conditions, such as otitis media, commonly known as ears infection. In some cases, health workers may prescribe fluoroquinolone remedy for the treatment of viral infection that would not respond to any antibiotic drugs. Another common use that can lead to fluoroquinolone resistance is the treatment of pneumonia obtained community with drugs such as ciprofloxacin.
For healthcare professionals who practice in areas that are expected to have high fluoroquinolone resistance, the standard of care for prescribing fluoroquinolones in each patient with symptoms similar to pneumonia. This practice is based on the possibilities that symptoms similar to pneumonia could be caused by undiagnosed tuberculosis. In some cases, the only course of treatment of antibiotics fluoroquinolone could lead drugs to the development of a resistant kmEne tuberculosis in this individual.
fluoroquinolones are considered a wide spectral antibiotics that are effective in the treatment of bacterial infections of a serious nature. These drugs are particularly recommended for patients who are sufficiently ill to require immediate hospitalization. One of the disadvantages of wide spectral antibiotics is their tendency to lead to the development of resistant bacterial strains. Many public health sources recommend that the use of fluoroquinolone drugs for minor infections.
The possible growth of the tribe of tuberculosis resistant to fluoroquinolone is considered to be concerned about the world medical community. Many other types of pathogens have already created strains resistant to these drugs. Resistant pathogens include some Streptococcus and Staphylococcus varieties.